NCT01328886 - Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Allergic Asthma

Interventions

DRUG

Omalizumab

omalizumab lyophilized 150 mg injection

Trial Locations (15)

Novartis Investigative Site, Ohbu

Novartis Investigative Site, Chiba

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Gifu

Novartis Investigative Site, Sagamihara

Novartis Investigative Site, Yokohama

Novartis Investigative Site, Yokohama

Novartis Investigative Site, Tsu

Novartis Investigative Site, Tenri

Novartis Investigative Site, Habikino

Novartis Investigative Site, Shimotsuka-gun

Novartis Investigative Site, Fuchū

Novartis Investigative Site, Komae

Novartis Investigative Site, Setagaya-ku

Novartis Investigative Site, Sumida-ku